Cell & Gene Collaborative Blog
-
“Science Over Steel:” Exploring The Foundations Of A Hybrid CGT Outsourcing Strategy
10/11/2022
This article is part one of a three-part series examining how advanced therapy scientific and quality-related challenges are impacting outsourcing models. We start first by unpacking the considerations ATMP innovators are faced with as they evaluate the increasingly popular hybrid outsourcing model.
-
ARW’s CGT+RNA Manufacturing Must-Reads (Post Card Edition!)
10/7/2022
Day-in and day-out, I write, read, listen to, and watch as much content as I can about CGT and RNA therapy manufacturing, in particular, and/or other ATMP industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email.
-
A (More) Mature mRNA Therapeutics Industry: 4 Best Practices To Get There
9/27/2022
Throughout the two-day mRNA Therapeutics Summit, there were four key takeaways that clearly demonstrated how the mRNA industry could incrementally achieve one speaker's industry prediction that, within the next 10 years, every person in the world will have had the opportunity to benefit from mRNA.
-
ARW’s CGT+RNA Manufacturing Must-Reads (Safari Edition!)
9/26/2022
Day-in and day-out, I write, read, listen to, and watch as much content as I can about CGT and RNA therapy manufacturing, in particular, and/or other ATMP industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email.
-
Equitable mRNA Therapies Demands Multi-Faceted Understanding Of Access & Innovation
9/19/2022
This article is the final installment in a four-part series unpacking several of the best practices shared during the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
mRNA Delivery Is More Than Just The Vehicle: Think Outside — & Inside — The LNP
9/14/2022
This article is part three of a four-part series unpacking my biggest takeaways from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
ARW's C&G + RNA Manufacturing Must-Reads (Acting Class Edition!)
9/11/2022
Day-in and day-out, I write, read, listen to, and watch as much content as I can about CGT and RNA therapy manufacturing, in particular, and/or other ATMP industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email.
-
To Advance An mRNA “Platform,” Forget Traditional Operational Structures
9/11/2022
This article is **part** **two** of a four-part series unpacking several best practices I gleaned from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
Don’t Get Uppity: Match mRNA Science To Your Capabilities — And Vice Versa
9/6/2022
This article is part one of a four-part series unpacking four of my biggest takeaways from the mRNA Therapeutics Summit, which took place in Boston on July 27 & 28, 2022.
-
ARW’s Cell & Gene + RNA Manufacturing Must-Reads (Class Reunion Edition!)
8/15/2022
Day-in and day-out, I write, read, listen to, and watch as much content as I can about CGT and RNA therapy manufacturing, in particular, and/or other ATMP industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email.